As of May 24, 2025, CorVel Corp (CRVL) reports a ROE (Return on Equity) of 30.79%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of CorVel Corp's ROE (Return on Equity)
Over recent years, CorVel Corp's ROE (Return on Equity) has shown a moderate pattern. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-03-31 | 30.79% |
| 2023-03-31 | 32.82% |
| 2022-03-31 | 31.27% |
| 2021-03-31 | 21.03% |
| 2020-03-31 | 24.97% |
This slight downward trend highlights how CorVel Corp manages its efficiency in generating profits from shareholders' equity over time.
Comparing CorVel Corp's ROE (Return on Equity) to Peers
To better understand CorVel Corp's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| CorVel Corp (CRVL) | 30.79% |
| DaVita Inc (DVA) | 773.06% |
| Oak Street Health Inc (OSH) | 187.83% |
| Aesthetic Medical International Holdings Group Ltd (AIH) | 67.02% |
| PharmChem Inc (PCHM) | 64.26% |
| Cryo-Cell International Inc (CCEL) | 49.79% |
Compared to its competitors, CorVel Corp's ROE (Return on Equity) is among the highest compared to peers, suggesting efficient use of shareholder equity to generate profits.